ClinicalTrials.govpublic full text
High-Dose Erythropoietin in Extremely Premature Infants to Prevent/Attenuate Brain Injury: A Phase II Study
infant, premature, erythropoietin, brain injury, intraventricular hemorrhage, periventricular leukomalacia, neurodevelopmental outcomes, randomized clinical trial, extreme prematurity, perinatal brain injury, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 916440
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.